MAPay, LLC, the global healthcare fintech company revolutionizing healthcare payments and data exchange with distributed ledger and Web3, announced a partnership with The Americas Continental Health Alliance.

The strategic collaboration will create a Web3 health and life science data ecosystem with MAPay’s innovative technologies at its core, connecting the ACHA’s data-rich system of healthcare professionals, researchers and Universities in Latin countries, will gain more efficient and secure access to technology, data transfer and real-world, real-time data.

“We observed ACHA’s flourishing network in Latin American countries and were delighted to augment the existing system with a future-proof ecosystem that enhances secure access to collect, store and share health and life science data digitally,” said Michael ‘Dersh’ Dershem, CEO of MAPay. “This agreement will allow ACHA to access MAPay’s technology, allowing its members to store their data safely and efficiently.”

ACHA & MAPay’s first collaboration activity will begin by sharing the added-value of the following solutions with the health and research sector:

  • Decentralized Digital Identity (DID): Provable, verifiable, authenticated digital identity that allows the exchange of data using privacy-preserving methods
  • Self-Sovereign (self-owned) Identity (SSI): Self-owned DID where the user can control their identity and decide who can use it, when, where and for how long

The intention of both organizations is to implement the mentioned solutions in the health and life sciences sectors.

“MAPay is the well-connected and seasoned global collaborator required to operate at the pinnacle of the hypersensitive health data environment,” said Johni Fisher, co-founder of ACHA. “The MAPay team impressed us with their knowledge of how to build cross-vertical partnerships in healthcare, life sciences, education, and humanitarian aid in emerging markets and developing economies.”

MAPay facilitates healthcare B2B2C cross-border value chain and payment systems to provide health and wealth products for underserved communities. This agreement with ACHA will provide education and technology transfer in Healthcare and Life Science, promote public health initiatives and facilitate international research and academic dialogue.